tiprankstipranks
Alterity Therapeutics Ltd. (AU:ATH)
ASX:ATH

Compare Alterity Therapeutics (ATH) vs. Competitors

35 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Alterity Therapeutics
AU$0.01
AU$97.88M
-2.12
0.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Actinogen Medical
AU$0.04
AU$136.48M
-4.28
40.74%
1 Buy
0 Hold
0 Sell
Moderate Buy
Cynata Therapeutics Limited
AU$0.29
AU$68.86M
-7.57
52.63%
Tryptamine Therapeutics
AU$48.52M
-9.56
-3.23%
Living Cell Technologies
AU$0.02
AU$25.29M
-6.84
40.00%
Neuren Pharmaceuticals Limited
AU$12.58
AU$1.59B
78.41
44.27%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AU:ATH
Alterity Therapeutics
0.01
0.00
0.00%
AU:ACW
Actinogen Medical
0.04
<0.01
35.71%
AU:CYP
Cynata Therapeutics Limited
0.29
0.09
48.72%
AU:ENP
Tryptamine Therapeutics
0.03
<0.01
3.45%
AU:1AI
Living Cell Technologies
0.01
<0.01
40.00%
AU:NEU
Neuren Pharmaceuticals Limited
12.58
3.01
31.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts